Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

American Express hails 'record' revenues, shares spark

(Sharecast News) - American Express forecast better-than-expected 2024 earnings on Friday, as its posted record full-year revenues. The US firm, which has a more affluent customer base than many other credit card providers, reported revenues of $60.52bn for 2023, a 14% increase or 15% once adjusted for forex.

Billed business - which represents the transaction value on Amex cards - rose 9% to $1.46trn.

Net income improved by 11% at $8.37bn, while diluted earnings per share rose 14% to $11.21.

Amex did, however, raise its loan loss provisions in the fourth quarter, to $1.44bn from $1.03bn a year earlier.

Borrowing has become more expensive in the US as the Federal Reserve, in common with many other central banks, hiked interest rates.

Stephen Squeri, chief executive, said: "We delivered record revenues and profits in 2023.

"We continued to drive strong customer engagement and demand for our premium products remained robust.

"Since January 2022, we've grown revenues by more that 40% and card member spending has increased by 37% to $1.5trn, an all-time high.

"These strong results demonstrate the strength of our premium customer base and the tremendous earnings power of our business model."

Amex is now forecasting revenue growth for the current year of between 9% and 11%, and EPS between $12.65 and $13.15. Analysts had forecast 2024 EPS of $12.41, according to Reuters.

Shares in the Wall Street-listed firm jumped as trading got underway, and were up 7% by 1445 GMT.

Share this article

Related Sharecast Articles

TSB appoints Marc Armengol as new CEO
(Sharecast News) - TSB said on Friday that it has appointed Marc Armengol as its new chief executive officer.
Genedrive full-year revenue rises
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Friday.
Former Bushveld subsidiary defaults on loan repayment
(Sharecast News) - Bushveld Minerals announced on Friday that Vanchem, a subsidiary it recently sold, has failed to repay ZAR 14.4m (£0.63m) plus accrued interest, which was due 21 November.
Atlantic Lithium progressing Ewoyaa despite mining lease delays
(Sharecast News) - Atlantic Lithium reported significant milestones in advancing the Ewoyaa Lithium Project in Ghana in an update on Friday, despite ongoing delays in the ratification of the project's mining lease.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.